Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
about
Widespread structural and functional connectivity changes in amyotrophic lateral sclerosis: insights from advanced neuroimaging research25 years of neuroimaging in amyotrophic lateral sclerosis.Data donation could power the learning health care system, including special access programs.Patterns of spontaneous brain activity in amyotrophic lateral sclerosis: a resting-state FMRI studyAltered patterns of cortical activation in ALS patients during attention and cognitive response inhibition tasks.Neural correlates of cognitive decline in ALS: an fNIRS study of the prefrontal cortexThe syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis.Imaging the role of GABA in movement disorders.Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.Lithium treatment in amyotrophic lateral sclerosis: do we have enough trials?A visual MRI atrophy rating scale for the amyotrophic lateral sclerosis-frontotemporal dementia continuum.A prospective cohort study of neuropsychological test performance in ALS.Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?Neuroimaging in the Management of Motor Neuron DiseasesThe range and clinical impact of cognitive impairment in French patients with ALS: A cross-sectional study of neuropsychological test performance
P2860
Q21285058-85C10182-DECF-4BF3-9964-BE94CD6D5802Q30659482-66312E53-FB4E-4302-B9BC-A15D300CB4F3Q30862343-95CEDEF7-432F-491A-A7FE-D52E9530722AQ34429131-8B07DDCA-4C9C-4D97-8071-FA0B7C1323ADQ35577391-561601FF-73C2-40E3-8527-84DD5D17C96BQ36504921-7F94B538-8F42-4385-A296-2D491B51BE54Q37254394-5F192A64-06F9-4B91-8DE6-ED05AC62AD7CQ38132714-808C6DD6-E0EA-418B-BC58-0E0FCDE5A7EDQ38868221-AF3DCCC7-2D1F-45A2-A082-D9BB8201CF6DQ39033807-E7C9EFE3-7C8E-4FDF-8998-5886859447F1Q41860558-FAFDA6ED-682A-4C62-AB87-6C431F0BAEA7Q47574212-FD6BAA21-F3DE-45A0-B666-5806D38D561FQ50659466-66BCD86B-4365-46CA-B26F-9CB74803D6D0Q51714285-3257CB5E-DFD6-451C-9DD5-B1C966D597BAQ57498880-EEB1D21F-0E6F-48DE-84AA-6CE32A7A98EEQ57498941-47C65723-6CCA-4174-AC05-9D1CD7C74E00Q58143657-79D42AAA-72D0-45EF-A1B4-2C12AE700CFF
P2860
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Neuronal loss associated with ...... an (11C)-flumazenil PET study.
@en
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an
@nl
type
label
Neuronal loss associated with ...... an (11C)-flumazenil PET study.
@en
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an
@nl
prefLabel
Neuronal loss associated with ...... an (11C)-flumazenil PET study.
@en
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an
@nl
P2860
P50
P1476
Neuronal loss associated with ...... an (11C)-flumazenil PET study.
@en
P2093
Sharon Abrahams
P2860
P356
10.1080/17482960701737716
P577
2008-02-01T00:00:00Z